Showing 1 - 12 results of 12 for search 'Saravanan Sekaran', query time: 0.02s Refine Results
  1. 1
    Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?

    Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer? by Saravanan Sekaran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing

    Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing by Saravanan Sekaran, Dhanraj Ganapathy

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?

    Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent? by Deepavalli Arumuganainar, Saravanan Sekaran

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies

    Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies by Bharathi Selvaraj, Saravanan Sekaran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy

    Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy by Saravanan Sekaran, Dhanraj Ganapathy

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer

    Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer by Dhanraj Ganapathy, Saravanan Sekaran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis

    miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis by Dhanraj Ganapathy, Saravanan Sekaran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Universal Repository for patients with oral cancer and oral premalignant lesions (UROC)

    Universal Repository for patients with oral cancer and oral premalignant lesions (UROC) by Dhanraj Ganapathy, Saravanan Sekaran, Pasiyappazham Ramasamy

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Intracellular microbiome in oral cancer progression

    Intracellular microbiome in oral cancer progression by Dhanraj Ganapathy, Saravanan Sekaran, Pasiyappazham Ramasamy

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression

    Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression by Dhanraj Ganapathy, Saravanan Sekaran, Pasiyappazham Ramasamy

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer

    Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer by Saravanan Sekaran, Dhanraj Ganapathy, Pitchiah Sivaperumal

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders

    Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders by Bharathi Selvaraj, Dhanraj Ganapathy, Saravanan Sekaran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: